TAZOMELINE CITRATE
UNII O494QX2F4D

Substance Identification & Data

This profile provides standardized clinical and technical data for Tazomeline Citrate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) O494QX2F4D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 175615-45-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

O494QX2F4D

CAS Registry Number

175615-45-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TAZOMELINE CITRATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C14H23N3S2.C6H8O7

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

WIOWZFAHNWMORW-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C66581

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

23209321

Unique identification number in the NCBI database of chemical substances.

USAN ID

HH-88

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C1CN(C)CC(=C1)c2nsnc2SCCCCCC.O=C(CC(CC(O)=O)(O)C(=O)O)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tazomeline Citrate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.